AJA
LIVE

Serial Number

97351877

Owner

MyCare MedTech Inc.

Attorney

Caroline G. Chicoine

Filing Date

Apr 7, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AJA Trademark

Serial Number: 97351877

AJA is a trademark filed by MyCare MedTech Inc. on April 7, 2022. The trademark is classified under Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

MyCare MedTech Inc. (3 trademarks)

235 366 Aspen Glen Landing SW
Calgary T3H0N5 , CA

Entity Type: 03

Trademark Details

Filing Date

April 7, 2022

Registration Date

Not Registered

Goods & Services

Direct marketing of the goods and services of others; providing one-to-one direct marketing of the goods and services of others; marketing services in the field of arranging for the distribution of the products of others; development of marketing strategies and concepts for others; advertising the goods and services of others; online retail store services and retail store services featuring therapeutics and nutraceuticals; distribution of therapeutic and nutraceutical products for advertising purposes; marketing services in the field of therapeutics and nutraceuticals

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 2, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 2, 2026 GNSL
SUSPENSION LETTER WRITTEN
Apr 2, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 1, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 31, 2026 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 14, 2026 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 14, 2026 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 14, 2026 CNSI
ASSIGNED TO EXAMINER
Jan 6, 2026 DOCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Aug 6, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 5, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 5, 2025 GNSL
SUSPENSION LETTER WRITTEN
Feb 5, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 30, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 30, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 29, 2025 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 29, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jan 29, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Jan 29, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 16, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 4, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 4, 2024 GNSL
SUSPENSION LETTER WRITTEN
Mar 4, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 2, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 1, 2024 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 26, 2024 GNS2
INQUIRY TO SUSPENSION E-MAILED
Feb 26, 2024 GNSI
SUSPENSION INQUIRY WRITTEN
Feb 26, 2024 CNSI
ASSIGNED TO EXAMINER
Feb 26, 2024 DOCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 28, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 28, 2023 GNSL
SUSPENSION LETTER WRITTEN
Aug 28, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2023 CRFA
ASSIGNED TO LIE
Aug 25, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2023 TROA
NOTIFICATION OF PRIORITY ACTION E-MAILED
Feb 13, 2023 GPRN
PRIORITY ACTION E-MAILED
Feb 13, 2023 GPRA
PRIORITY ACTION WRITTEN
Feb 13, 2023 CPRA
ASSIGNED TO EXAMINER
Jan 25, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 12, 2022 NWOS
NEW APPLICATION ENTERED
Apr 11, 2022 NWAP